Evaluation of revisited fucosylated alpha-fetoprotein (AFP-L3) with an autoanalyzer μTAS in a clinical laboratory

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 170-174

  Choi, Jonghyeon ^a   Park, Yongjung ^a   Kim, Jeong Ho ^a   Kim, Hyon Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

AFP L3; Alpha fetoprotein (AFP); Lens culinaris agglutinin (LCA); Liquid phase binding assay

Indexed keywords

ALPHA FETOPROTEIN; FUCOSYLATED ALPHA FETOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; AUTOANALYZER; BINDING ASSAY; BLOOD SAMPLING; CLINICAL LABORATORY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICRO TOTAL ANALYSIS SYSTEM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

AGED; ALPHA-FETOPROTEINS; FEMALE; FUCOSE; HUMANS; LABORATORIES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

LENS CULINARIS;

EID: 82955167852     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.015     Document Type: Article

References (19)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Kim D.Y., Paik Y.H., Ahn S.H., et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 2007, 72(Suppl. 1):52-57.
3. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986, 6:729-738.
4. Matsuda M., Asakawa M., Amemiya H., Fujii H. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC. J Gastroenterol Hepatol 2011, 26:731-738.
5. Sherman M., Peltekian K.M., Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995, 22:432-438.
6. Cui R., He J., Zhang F., et al. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br J Cancer 2003, 88:1878-1882.
7. Aoyagi Y., Isemura M., Suzuki Y., et al. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells. Lancet 1986, 1:210.
8. Hayashi K., Kumada T., Nakano S., et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 1999, 94:3028-3033.
9. Li D., Mallory T., Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 2001, 313:15-19.
10. Nouso K., Kobayashi Y., Nakamura S., et al. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein. J Gastroenterol Hepatol 2011, 26(7):1195-1200.
11. Kagebayashi C., Yamaguchi I., Akinaga A., et al. Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 2009, 388:306-311.
12. Kawahara N., Ohta M., Liu M., Taga H., Taketa K., Kudo T. Developmental alterations in the alpha-fetoprotein sugar chain in maternal serum analyzed by lectin affinity electrophoresis. Acta Med Okayama 1999, 53:103-110.
13. Koutny L.B., Schmalzing D., Taylor T.A., Fuchs M. Microchip electrophoretic immunoassay for serum cortisol. Anal Chem 1996, 68:18-22.
14. Chiem N., Harrison D.J. Microchip-based capillary electrophoresis for immunoassays: analysis of monoclonal antibodies and theophylline. Anal Chem 1997, 69:373-378.
15. Block T.M., Marrero J., Gish R.G., et al. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop. Cancer Biomark 2008, 4:19-33.
16. Nakagawa T., Miyoshi E., Yakushijin T., et al. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients. J Proteome Res 2008, 7:2222-2233.
17. Morota K., Nakagawa M., Sekiya R., et al. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, alpha-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Clin Chem Lab Med 2011, 49:711-718.
18. Kawabata T., Watanabe M., Nakamura K., Satomura S. Liquid-phase binding assay of alpha-fetoprotein using DNA-coupled antibody and capillary chip electrophoresis. Anal Chem 2005, 77:5579-5582.
19. Sato S., Toyota J., Kagebayashi C., Kurosawa T., Watanabe M., Satomura S. Evaluation of a new, microfluidic chip-based immunoassay for measurement of AFP-L3. Rinsho Byori 2010, 58:1155-1161.